Robbins Farley’s AstraZeneca AZN Stock Holding History

Robbins Farley’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.86M	Buy	25,635 +498	+2%	+$93.7K	1.87%	25
2026 Q1	$4.96M	Buy	25,137 +184	+0.7%	+$35.5K	2.19%	19
2025 Q4	$4.59M	Sell	24,953 -2,122	-8%	-$372K	2.08%	22
2025 Q3	$4.15M	Buy	27,075 +13,791	+104%	+$2.09M	1.73%	29
2025 Q2	$1.86M	Buy	+13,284	New	+$1.86M	0.86%	45
2023 Q4	–	Sell	-200	Closed	-$27.1K	–	178
2023 Q3	$27.1K	Hold	200	–	–	0.02%	95
2023 Q2	$28.6K	Hold	200	–	–	0.02%	85
2023 Q1	$27.8K	Hold	200	–	–	0.02%	89
2022 Q4	$27.1K	Hold	200	–	–	0.02%	84
2022 Q3	$22K	Hold	200	–	–	0.02%	78
2022 Q2	$26K	Buy	+200	New	+$26.2K	0.03%	58
2022 Q1	–	Sell	-200	Closed	-$23K	–	132
2021 Q4	$23K	Hold	200	–	–	0.02%	69
2021 Q3	$24K	Hold	200	–	–	0.02%	77
2021 Q2	$24K	Hold	200	–	–	0.03%	47
2021 Q1	$22K	Buy	+200	New	+$20.1K	0.02%	78

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Robbins Farley's AZN Position: Q2 2026 in Review

Robbins Farley increased its AstraZeneca (AZN) stake by 2% in Q2 2026, buying an estimated $93.7K and bringing the position to 25,635 shares worth $4.86M. The position accounts for 1.87% of the portfolio, ranked #25.

Robbins Farley first reported a position in AZN in Q1 2021 and has held it in 15 quarters since. The position peaked at $4.96M in Q1 2026. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Robbins Farley held 25,635 shares of AstraZeneca worth $4.86M as of Q2 2026.
Robbins Farley bought 498 AstraZeneca shares in Q2 2026, an estimated $93.7K.
AstraZeneca made up 1.87% of Robbins Farley's portfolio in Q2 2026, its #25 holding.
Robbins Farley first reported a position in AstraZeneca in Q1 2021 and has held it in 15 quarters since.
Robbins Farley's AstraZeneca position peaked at $4.96M in Q1 2026.
1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Robbins Farley's 13F filing for Q2 2026, filed 23 Jul 2026.